Home / Indicator library / Biotechnology and Medical Care / CCSB (1762) overview
CCSB (1762) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for CCSB, on one pageCCSB (1762) snapshot, key figures
CCSB (1762): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→1762: common questions
What is 1762's price-to-book ratio?
1762's price-to-book ratio was 0.78x on 2026-08-03, taken as-is from the official public source.
How fast is 1762's revenue growing?
1762 reported -40.2% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 1762's price / book high or low right now?
1762's price / book is 0.78x, which is above its one-year median of 0.65x and sits at the 75th percentile of the 0.58–1.02x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.